Trials / Completed
CompletedNCT02561468
The Preemptive Analgesic Efficacy of Nefopam
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 94 (actual)
- Sponsor
- Seoul National University Bundang Hospital · Academic / Other
- Sex
- Female
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Nefopam is administered as a preemptive analgesic drug to the patient undergoing breast cancer surgery. It will be evaluated whether postoperative acute and chronic pain can be reduced.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nefopam | |
| DRUG | Saline |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2016-01-01
- Completion
- 2016-01-01
- First posted
- 2015-09-28
- Last updated
- 2016-04-06
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02561468. Inclusion in this directory is not an endorsement.